Payments to Acquire Property, Plant, and Equipment of Pacira BioSciences, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Pacira BioSciences, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Pacira BioSciences, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $8,548,000, a 201% increase year-over-year.
  • Pacira BioSciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $15,333,000, a 44% increase from 2024.
  • Pacira BioSciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $10,636,000, a 30% decline from 2023.
  • Pacira BioSciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $15,161,000, a 50% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Pacira BioSciences, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,333,000 +$4,697,000 +44% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $10,636,000 -$4,525,000 -30% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $15,161,000 -$14,915,000 -50% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $30,076,000 -$15,790,000 -34% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $45,866,000 +$8,065,000 +21% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $37,801,000 +$27,642,000 +272% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $10,159,000 -$4,355,000 -30% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $14,514,000 -$4,752,000 -25% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $19,266,000 -$5,443,000 -22% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $24,709,000 -$15,586,000 -39% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $40,295,000 +$17,311,000 +75% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $22,984,000 +$10,812,000 +89% 01 Jan 2014 31 Dec 2014 10-K 25 Feb 2016 2015 FY
2013 $12,172,000 -$6,085,000 -33% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $18,257,000 +$12,090,000 +196% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
2011 $6,167,000 -$603,000 -8.9% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 $6,770,000 01 Jan 2010 31 Dec 2010 10-K 07 Mar 2013 2012 FY

Pacira BioSciences, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $8,548,000 +$5,712,000 +201% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $2,836,000 -$3,729,000 -57% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $6,565,000 -$1,103,000 -14% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $7,668,000 -$5,405,000 -41% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $13,073,000 +$6,349,000 +94% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $6,724,000 +$4,706,000 +233% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $2,018,000 -$3,166,000 -61% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $5,184,000 +$1,568,000 +43% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $3,616,000 -$3,437,000 -49% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $7,053,000 -$821,000 -10% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $7,874,000 +$4,066,000 +107% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q4 2014 $22,984,000 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q1 2014 $3,808,000 +$876,000 +30% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q1 2013 $2,932,000 +$31,000 +1.1% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q1 2012 $2,901,000 +$2,069,000 +249% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q1 2011 $832,000 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.